GEN Announces New Positive Phase 1 Trial Data of the Investigational Drug SUL-238 for Alzheimer’s and Other Neurodegenerative Diseases
ANKARA, Turkey, Dec 2, 2025 – (ACN Newswire) – GEN Pharmaceuticals (GENIL.IS), Türkiye’s leading specialty pharmaceutical…
New Survey Highlights Gap Between Perceived AI Readiness And Tested Disaster Recovery Capability
Syngenta Deploys Tetra OS to Accelerate Scientific Discovery Through Industrial-Scale Data Automation